The drug developer said that the biomarker panel will form the basis of a planned point-of-care test for acute respiratory distress syndrome.
The company will provide counseling in multiple languages and connect people to local healthcare resources so they can use the genetic information they've learned in their own care.
The researchers identified genes that specifically extend the lifespan of neurons and found genes that increase the number of neurites in the brain.
The NAM, NAS, and Royal Society have formed a commission to develop a framework on the proper use of genome editing, and convened its first meeting in Washington, DC, this week.
ScienceInsider reports that researchers funded through the Cancer Moonshot program will have to make their papers immediately accessible to the public.
The US National Institutes of Health outlines how it will be handling restrictions on fetal tissue research, according to ScienceInsider.
Researchers identified a new type 2 diabetes-associated site involving the ZRANB3 gene, which may have a role in regulating pancreatic beta cells.
National Institutes of Health Director Francis Collins tells NPR he has mostly received support for his pledge to avoid all-male scientific panels.
Science reports that the US National Institutes of Health's push to enforce disclosure of foreign ties may have led to the quiet dismissal of other researchers.
During an NIH meeting, researchers from four newborn sequencing research projects discussed results of their studies and future implications.
According to Wired, Nebula Genomics is providing a way for people to get their genomes sequenced anonymously.
NPR says the explosion and fire earlier this week at a Russian lab that stores dangerous pathogens revives the question of whether such samples should be kept.
A 26-year-old woman tells Cosmopolitan about learning her APOE status at a young age.
In Science journals this week: a functional genomic screen uncovers drug combination that increases KRAS inhibitor efficacy in aggressive lung cancer, and more.